强生亮相2025服贸会，多款全球领先产品首秀

Core Viewpoint - Johnson & Johnson showcased its medical technology and innovative pharmaceutical divisions at the 2025 China International Fair for Trade in Services, highlighting breakthrough innovative products and localized solutions that integrate global research capabilities with Chinese clinical insights [1] Group 1: Product Highlights - Two major products made their debut at the fair: the Impella CP with SmartAssist, an interventional left ventricular assist device for heart failure treatment, and the injection of Nikalimab, aimed at treating specific antibody-positive generalized myasthenia gravis in adults and adolescents aged 12 and above [1]